Twist Bioscience Corporation — Balance Sheet Charts
8 snapshots of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Working Capital Components
Capital Structure (LT Debt / Cash / Equity)
Total Assets↑+4.8% +$30M
$638M
Current Assets↓-12.0% -$41M
$304M
Cash & Equivalents↓-32.9% -$73M
$149M
ST Investments↓-0.1% -$66K
$49M
Receivables↑+27.3% +$11M
$50M
Inventory↑+40.0% +$9M
$33M
Net PPE↑+4.4% +$4M
$105M
Goodwill↓-4.2% -$4M
$82M
Intangibles↓-7.4% -$1M
$13M
Total Liabilities↑+19.2% +$29M
$182M
Current Liabilities↑+15.5% +$11M
$80M
Account Payables↑+66.5% +$5M
$12M
Long-Term Debt
—
Stockholders Equity↑+0.0% +$154K
$456M
Retained Earnings↓-6.0% -$77M
$-1.35B
Operating Lease ROU Asset↑+28.0% +$16M
$72M
Operating Lease Liability↑+18.7% +$15M
$98M
Gross PP&E↑+12.8% +$23M
$205M
Accumulated Depreciation↑+23.1% +$19M
$100M
Inventory Raw Materials↑+53.9% +$9M
$25M
Inventory WIP↓-12.0% -$317K
$2M
Inventory Finished Goods↑+22.4% +$1M
$6M
Debt Due Y1
—
Debt Due Y2
—
Debt Due Y3
—
Total Debt Carrying Amount
—
Contract Asset↑+569.5% +$10M
$12M
Contract Liability↑+552.9% +$8M
$9M
Contract Liability (Current)
—
Remaining Performance Obligation↑+134.6% +$11M
$19M